[Serologic markers of viral hepatitis B in drug addicted++ patients at the Hermilio Valdizan Hospital] NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[Serologic markers of viral hepatitis B in drug addicted++ patients at the Hermilio Valdizan Hospital]

Rev Gastroenterol Peru. 1989;9(2):95-9. Unique Identifier : AIDSLINE MED/92032807
Farfan G; Vidal J; Phillips I; Llerena S; Departamento de Medicina, Hospital Cayetano Heredia, UPCH, Lima,; Peru.

Abstract: A study was done in 36 drug addict patients at the H. Valdizan Hospital We studied serological markers for Hepatitis B: HBsAg Anti-HBc, and anti-HIV was also made. They were not IV abusers. Five patients (13.8%) were positive for HBsAg and 6 (16.6%) for anti-HBc. Anti-HIV was negative in all the cases, that obtained from our results compared with the general adult population from peruvian coast are high. In relation to the information obtained, the transmission route would be diverse, considering an important one the sexual route. 44 drug addicts were seen in 1988 at this Hospital, 36 cases could be a representative number, although we think we need to extend this study to a bigger population to establish the actual prevalence of this infection among these particular patients. This information could help to advice preventive and control health measures.
Keywords: Adolescence Adult English Abstract Hepatitis B Antibodies/*BLOOD Hepatitis B Antigens/*BLOOD Hospitals Human Male Peru Risk Factors Substance Dependence/*BLOOD JOURNAL ARTICLEKWDadolescenceadultenglishabstracthepatitisbantibodies/KWDbloodhepatitisbantigens/KWDbloodhospitalshumanmaleperuriskfactorssubstancedependence/KWDbloodjournalarticle
920228
M9220871

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .